The announcement was made after market hours yesterday, 21 February 2017.
Meanwhile, the S&P BSE Sensex was up 107.06 points, or 0.37%, to 28,868.65.
On the BSE, 4,025 shares were traded on the counter so far as against the average daily volumes of 10,103 shares in the past one quarter. The stock had hit a high of Rs 1,320.50 and a low of Rs 1,291.90 so far during the day.
The stock had hit a record high of Rs 1,544 on 2 March 2016 and a 52-week low of Rs 1,110.75 on 26 December 2016. The stock had outperformed the market over the past one month till 21 February 2017, advancing 11.16% compared with the Sensex's 6.39% rise. The scrip had also outperformed the market over the past one quarter gaining 11.64% as against the Sensex's 11.63% rise.
The large-cap company has equity capital of Rs 69.56 crore. Face value per share is Rs 5.
Apollo Hospitals Enterprise announced that a meeting of the debenture allotment committee of the board of directors of the company will be held on 23 February 2017, to consider and approve the allotment of 2,000 secured redeemable non-convertible debentures of face value of Rs 10 lakhs each aggregating to Rs 200 crore to institutional investors/banks/financial institutions on a private placement basis.
Apollo Hospitals Enterprise' net profit fell 40.5% to Rs 72.83 crore on 17.9% increase in net sales to Rs 1,680.61 crore in Q3 December 2016 over Q3 December 2015.
Apollo Hospitals is one of Asia's largest healthcare groups.
|